EE50 A Cost-Consequence Model of Using the 21-Gene Breast Recurrence Score Assay to Identify Patients with Early-Stage Node-Positive Breast Cancer Who Benefit from Adjuvant Chemotherapy in the Netherlands

Martijn J. H. G. Simons, Peter M. Machielsen,Jelle A. Spoorendonk, Tim Ignacio,Pieter B. Drost, Tim Jacobs,Felix E. de Jongh

Value in Health（2022）

引用 0|浏览0

关键词

21-gene,gene expression profiling,early stage,hormone receptor,human epidermal growth factor receptor 2,breast cancer,lymph node positive,adjuvant chemotherapy,cost-consequence analysis,A11,A1,C21,C2,C51,C5

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要